Paul Tudor Jones's CME Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 152,462 shares of CME Group Inc. (CME) worth $41.63 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2013, adding 330,066 shares. Largest reduction occurred in Q1 2014, reducing 335,398 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +92,462 | Add 154.10% | 152,462 | $273.08 |
| Q3 2025 | -47,187 | Reduce 44.02% | 60,000 | $270.19 |
| Q2 2025 | +47,187 | Add 78.64% | 107,187 | $275.62 |
| Q4 2024 | -55 | Reduce 0.09% | 60,000 | $232.23 |
| Q3 2024 | +55 | Add 0.09% | 60,055 | $220.65 |
| Q2 2024 | -186 | Reduce 0.31% | 60,000 | $196.60 |
| Q1 2024 | +186 | Add 0.31% | 60,186 | $215.29 |
| Q4 2023 | -1 | Reduce 0.00% | 60,000 | $210.60 |
| Q3 2023 | -51,551 | Reduce 46.21% | 60,001 | $200.22 |
| Q2 2023 | -5,809 | Reduce 4.95% | 111,552 | $185.29 |
| Q1 2023 | -25,854 | Reduce 18.05% | 117,361 | $0.19 |
| Q4 2022 | +16,223 | Add 12.77% | 143,215 | $0.17 |
| Q3 2022 | +66,770 | Add 110.87% | 126,992 | $177.13 |
| Q2 2022 | -9,106 | Reduce 13.13% | 60,222 | $204.69 |
| Q1 2022 | +7,292 | Add 11.75% | 69,328 | $237.85 |
| Q4 2021 | -6,903 | Reduce 10.01% | 62,036 | $228.46 |
| Q3 2021 | +1,799 | Add 2.68% | 68,939 | $193.37 |
| Q2 2021 | +7,140 | Add 11.90% | 67,140 | $212.68 |
| Q1 2021 | -22 | Reduce 0.04% | 60,000 | $204.23 |
| Q4 2020 | -562 | Reduce 0.93% | 60,022 | $182.05 |
| Q3 2020 | -5,794 | Reduce 8.73% | 60,584 | $167.30 |
| Q2 2020 | +6,378 | Add 10.63% | 66,378 | $162.54 |
| Q1 2020 | -11 | Reduce 0.02% | 60,000 | $172.92 |
| Q4 2019 | -54 | Reduce 0.09% | 60,011 | $200.71 |
| Q2 2019 | -11,187 | Reduce 15.70% | 60,065 | $194.11 |
| Q1 2019 | +11,187 | Add 18.62% | 71,252 | $164.58 |
| Q2 2018 | -654 | Reduce 1.08% | 60,065 | $163.92 |
| Q1 2018 | -5,211 | Reduce 7.90% | 60,719 | $161.75 |
| Q4 2017 | -2,729 | Reduce 3.97% | 65,930 | $146.05 |
| Q3 2017 | +18,838 | Add 37.81% | 68,659 | $135.69 |
| Q2 2017 | -5,898 | Reduce 10.59% | 49,821 | $125.25 |
| Q1 2017 | +8,119 | Add 17.06% | 55,719 | $118.79 |
| Q4 2016 | -1,193 | Reduce 2.45% | 47,600 | $115.36 |
| Q3 2016 | -71,248 | Reduce 59.35% | 48,793 | $104.52 |
| Q2 2016 | +82,071 | Add 216.15% | 120,041 | $97.40 |
| Q1 2016 | -4,495 | Reduce 10.59% | 37,970 | $96.05 |
| Q4 2015 | -21,307 | Reduce 33.41% | 42,465 | $90.59 |
| Q3 2015 | -65,328 | Reduce 50.60% | 63,772 | $92.74 |
| Q2 2015 | +94,200 | Add 269.91% | 129,100 | $93.06 |
| Q1 2015 | -1,101 | Reduce 3.06% | 34,900 | $94.70 |
| Q4 2014 | +6,001 | Add 20.00% | 36,001 | $88.64 |
| Q3 2014 | -2,900 | Reduce 8.81% | 30,000 | $79.97 |
| Q2 2014 | +1,100 | Add 3.46% | 32,900 | $70.94 |
| Q1 2014 | -335,398 | Reduce 91.34% | 31,800 | $74.03 |
| Q4 2013 | +330,066 | Add 888.90% | 367,198 | $78.46 |
| Q3 2013 | -19,400 | Reduce 34.32% | 37,132 | $73.87 |
| Q2 2013 | +56,533 | Add 0.00% | 56,532 | $75.96 |
Paul Tudor Jones's CME Group Investment FAQs
Paul Tudor Jones first purchased CME Group Inc. (CME) in Q2 2013, acquiring 56,532 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held CME Group Inc. (CME) for 51 quarters since Q2 2013.
Paul Tudor Jones's largest addition to CME Group Inc. (CME) was in Q4 2013, adding 367,198 shares worth $28.81 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 152,462 shares of CME Group Inc. (CME), valued at approximately $41.63 M.
As of the Q4 2025 filing, CME Group Inc. (CME) represents approximately 0.08% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in CME Group Inc. (CME) was 367,198 shares, as reported at the end of Q4 2013.